In patients who relapsed after, or are refractory to, a rituximab product-containing regimen
Follicular lymphoma dosing schedule 1
- Patients who achieve a CR, PR, or SD to the first 6 cycles of GAZYVA + bendamustine should continue on GAZYVA monotherapy every 2 months for up to 2 years
- If a planned dose of GAZYVA is missed, administer the missed dose as soon as possible. During GAZYVA and chemotherapy treatment, adjust the dosing schedule accordingly to maintain the time interval between chemotherapy cycles. During monotherapy, maintain the original dosing schedule for subsequent doses. Monotherapy should be initiated approximately two months after the last dose of GAZYVA administered during the induction phase
CR, complete response; PR, partial response; SD, stable disease.